Medicare Enrolled
Dr. Jeffrey Silberberg, M.D.
Hematology & Oncology · Freehold, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Silberberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Silberberg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Silberberg
Dr. Jeffrey Silberberg is a hematology & oncology specialist in Freehold, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Silberberg performed 109,443 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Silberberg received a total of $13,077 from 92 pharmaceutical and/or device companies across 814 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Silberberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in NJ
$13,077 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗109,443
Medicare services
Top 7% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
31,500 | $1 | $4 |
| Pembrolizumab injection (Keytruda) | 25,600 | $43 | $132 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
11,900 | $6 | $48 |
| Anti-nausea injection (aprepitant) | 5,590 | $1 | $8 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
5,000 | $0 | $2 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
2,840 | $36 | $182 |
| Denosumab injection (Prolia/Xgeva) | 2,820 | $18 | $66 |
| Iron infusion (Monoferric) | 2,500 | $16 | $71 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,470 | $8 | $18 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,461 | $8 | $32 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,138 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 1,860 | $0 | $19 |
| Injection, granisetron, extended-release, 0.1 mg | 1,700 | $5 | $20 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,540 | $6 | $29 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,354 | $101 | $230 |
| Injection, leucovorin calcium, per 50 mg | 898 | $3 | $25 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
852 | $108 | $901 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
670 | $25 | $131 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
612 | $2 | $12 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
587 | $12 | $85 |
| Anti-nausea injection (ondansetron/Zofran) | 456 | $0 | $3 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
443 | $99 | $231 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
431 | $13 | $92 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
411 | $115 | $591 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
368 | $73 | $151 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
297 | $1 | $13 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
282 | $2 | $270 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
272 | $1 | $6 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
239 | $145 | $310 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
194 | $54 | $261 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
183 | $17 | $82 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
176 | $145 | $420 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
134 | $25 | $126 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
118 | $57 | $288 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
103 | $63 | $201 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $135 | $352 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
60 | $49 | $261 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
50 | $150 | $899 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
49 | $1 | $16 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
47 | $17 | $82 |
| New patient office visit, complex (60-74 min) | 37 | $176 | $444 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
32 | $10 | $63 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
31 | $108 | $301 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
25 | $30 | $114 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
23 | $2 | $13 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $33 | $93 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
35.2% high complexity
57.5% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,077
Total received (2018-2024)
Avg $1,868/year across 7 years
Top 23% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
92
Companies
814
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,738
2023
$2,665
2022
$2,412
2021
$1,693
2020
$845
2019
$1,440
2018
$1,283
Payments by company (2024)
Daiichi Sankyo Inc.
$300
PFIZER INC.
$241
Novartis Pharmaceuticals Corporation
$140
Astellas Pharma US Inc
$137
Incyte Corporation
$132
Eisai Inc.
$126
Takeda Pharmaceuticals U.S.A., Inc.
$112
Bayer Healthcare Pharmaceuticals Inc.
$112
Merck Sharp & Dohme LLC
$96
ABBVIE INC.
$92
AstraZeneca Pharmaceuticals LP
$88
E.R. Squibb & Sons, L.L.C.
$79
Regeneron Healthcare Solutions, Inc.
$68
Gilead Sciences, Inc.
$65
Adaptive Biotechnologies Corporation
$61
Exelixis Inc.
$55
Celgene Corporation
$49
Lilly USA, LLC
$49
BeiGene USA, Inc.
$48
Alnylam Pharmaceuticals Inc.
$45
Pharmacosmos Therapeutics Inc.
$41
Aveo Pharmaceuticals, Inc.
$41
SERVIER PHARMACEUTICALS LLC
$37
SOBI, INC
$36
GlaxoSmithKline, LLC.
$36
Janssen Biotech, Inc.
$33
PUMA BIOTECHNOLOGY, INC.
$33
Rigel Pharmaceuticals, Inc.
$26
Genmab U.S., Inc.
$24
TAIHO ONCOLOGY, INC.
$22
Myriad Genetic Laboratories, Inc.
$22
Stemline Therapeutics Inc.
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
Genentech USA, Inc.
$20
Blueprint Medicines Corporation
$20
SpringWorks Therapeutics, Inc.
$19
Kyowa Kirin, Inc.
$18
Kite Pharma, Inc.
$17
Spectrum Pharmaceuticals Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Ipsen Biopharmaceuticals, Inc
$17
EMD Serono, Inc.
$16
Acrotech Biopharma Inc.
$16
Coherus Biosciences Inc.
$16
Octapharma USA, Inc.
$15
Mirati Therapeutics, Inc.
$15
Deciphera Pharmaceuticals Inc.
$15
GENZYME CORPORATION
$14
Top 3 companies account for 24.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$885
E.R. Squibb & Sons, L.L.C.
$802
Daiichi Sankyo Inc.
$630
Janssen Biotech, Inc.
$592
PFIZER INC.
$572
Merck Sharp & Dohme Corporation
$569
Merck Sharp & Dohme LLC
$422
AstraZeneca Pharmaceuticals LP
$406
Celgene Corporation
$379
Seagen Inc.
$326
Genentech USA, Inc.
$322
Incyte Corporation
$319
Astellas Pharma US Inc
$315
Eisai Inc.
$301
Takeda Pharmaceuticals U.S.A., Inc.
$300
GENZYME CORPORATION
$298
Bayer HealthCare Pharmaceuticals Inc.
$294
Pharmacyclics LLC, An AbbVie Company
$287
GlaxoSmithKline, LLC.
$264
Lilly USA, LLC
$244
Amgen Inc.
$229
Gilead Sciences, Inc.
$215
EMD Serono, Inc.
$192
Pharmacosmos Therapeutics Inc.
$183
Bayer Healthcare Pharmaceuticals Inc.
$178
Kite Pharma, Inc.
$172
ABBVIE INC.
$146
Seattle Genetics, Inc.
$146
Puma Biotechnology, Inc.
$142
Coherus Biosciences Inc.
$141
Regeneron Healthcare Solutions, Inc.
$134
AbbVie Inc.
$114
Blueprint Medicines Corporation
$111
Exelixis Inc.
$105
Taiho Oncology, Inc.
$102
PUMA BIOTECHNOLOGY, INC.
$91
ARRAY BIOPHARMA INC
$86
EISAI INC.
$85
Adaptive Biotechnologies Corporation
$76
Apellis Pharmaceuticals, Inc.
$75
BeiGene USA, Inc.
$75
MorphoSys, US Inc.
$72
Dendreon Pharmaceuticals LLC
$68
Alnylam Pharmaceuticals Inc.
$65
AbbVie, Inc.
$63
Stemline Therapeutics Inc.
$60
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
Foundation Medicine, Inc.
$58
Epizyme, Inc.,
$57
AVEO Pharmaceuticals, Inc.
$56
Acrotech Biopharma LLC
$54
SERVIER PHARMACEUTICALS LLC
$54
Karyopharm Therapeutics Inc.
$51
CTI BioPharma Corp.
$47
SUN PHARMACEUTICAL INDUSTRIES INC.
$46
Mirati Therapeutics, Inc.
$44
Alexion Pharmaceuticals, Inc.
$44
Octapharma USA, Inc.
$41
Array BioPharma Inc.
$41
Aveo Pharmaceuticals, Inc.
$41
Spectrum Pharmaceuticals Inc.
$40
TAIHO ONCOLOGY, INC.
$39
SOBI, INC
$36
Janssen Pharmaceuticals, Inc
$34
Acrotech Biopharma Inc.
$34
G1 Therapeutics, Inc.
$33
Kyowa Kirin, Inc.
$33
Ipsen Biopharmaceuticals, Inc
$32
Jazz Pharmaceuticals Inc.
$31
Deciphera Pharmaceuticals Inc.
$29
Myovant Sciences Inc.
$29
Rigel Pharmaceuticals, Inc.
$26
JAZZ PHARMACEUTICALS INC.
$25
Acceleron Pharma, Inc.
$24
Genmab U.S., Inc.
$24
Myriad Genetic Laboratories, Inc.
$22
Novocure Inc.
$21
Sun Pharmaceutical Industries Inc.
$19
SpringWorks Therapeutics, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$17
Sumitomo Pharma America, Inc.
$15
TESARO, Inc.
$15
Pharmacyclics LLC, an AbbVie Company
$15
SANOFI-AVENTIS U.S. LLC
$15
PharmaEssentia USA Corporation
$14
Agios Pharmaceuticals, Inc.
$14
Fortovia Therapeutics, Inc.
$14
Helsinn Therapeutics (U.S.), Inc.
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$13
Sobi, Inc
$12
Teva Pharmaceuticals USA, Inc.
$11
Secura Bio, Inc.
$11
Top 3 companies account for 17.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALUNBRIG · AMVUTTRA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CEREZYME · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Empaveli · Enhertu · Epkinly · Erleada · FARYDAK · FASENRA · FOLOTYN · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · FRUZAQLA · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · Monoferric · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · Reblozyl · Revlimid · Rezlidhia · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Stivarga · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tibsovo · Trodelvy · Udenyca · Ultomiris · VALCHLOR · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · WILATE · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
86
County median income
$122,727
Nearest hospital to ZIP centroid (approximate)
CENTRASTATE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Silberberg is a mixed practice specialist, with above-average Medicare volume (top 7% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Silberberg experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Silberberg performed 31,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Silberberg receive payments from pharmaceutical companies?
Yes. Dr. Silberberg received a total of $13,077 from 92 companies across 814 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Silberberg's costs compare to other hematology & oncology specialists in Freehold?
Dr. Silberberg's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Silberberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Freehold
Browse hematology & oncology specialists in Freehold ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology